Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1977 Feb;53(616):61-5.
doi: 10.1136/pgmj.53.616.61.

Double-blind comparison of verapamil and practolol in the treatment of angina pectoris

B Fagher, S Persson, S E Svensson
Clinical Trial

Double-blind comparison of verapamil and practolol in the treatment of angina pectoris

B Fagher et al. Postgrad Med J. 1977 Feb.

Abstract

In thirteen patients with coronary insufficiency and angina pectoris the therapeutic effects of verapamil, 80 mg three times/day and practolol, 100 mg three times/day, were compared and tested against placebo in a double-blind cross-over fashion. Verapamil proved to be the most efficient drug as regards attack frequency and glyceryl trinitrate consumption as well as physical working capacity, bringing about a statistically significant increase of the exercise tolerance as compared to placebo after a treatment period of four weeks. Verapamil is a good alternative to beta-blockers in the prophylactic treatment of angina. Possible modes of action of verapamil in angina pectoris are discussed. The study had to be interrupted because of the reports of side effects of practolol, explaining the small number of patients.

PubMed Disclaimer

References

    1. Drugs. 1974;7(1):55-84 - PubMed
    1. Drugs. 1974;7(1):118-29 - PubMed
    1. Br Med J. 1970 May 16;2(5706):399-402 - PubMed
    1. Cardiovasc Res. 1972 Mar;6(2):120-8 - PubMed
    1. Br Med J. 1974 Nov 9;4(5940):321-4 - PubMed